These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

462 related articles for article (PubMed ID: 22633603)

  • 1. Alpinetin/hydroxypropyl-β-cyclodextrin host-guest system: preparation, characterization, inclusion mode, solubilization and stability.
    Ma SX; Chen W; Yang XD; Zhang N; Wang SJ; Liu L; Yang LJ
    J Pharm Biomed Anal; 2012; 67-68():193-200. PubMed ID: 22633603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation and characterization of inclusion complexes of naringenin with β-cyclodextrin or its derivative.
    Yang LJ; Ma SX; Zhou SY; Chen W; Yuan MW; Yin YQ; Yang XD
    Carbohydr Polym; 2013 Oct; 98(1):861-9. PubMed ID: 23987422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of inclusion complex of epothilone A with cyclodextrins.
    Xiao CF; Li K; Huang R; He GJ; Zhang JQ; Zhu L; Yang QY; Jiang KM; Jin Y; Lin J
    Carbohydr Polym; 2014 Feb; 102():297-305. PubMed ID: 24507285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Host-guest system of nimbin and beta-cyclodextrin or its derivatives: preparation, characterization, inclusion mode, and solubilization.
    Yang LJ; Yang B; Chen W; Huang R; Yan SJ; Lin J
    J Agric Food Chem; 2010 Aug; 58(15):8545-52. PubMed ID: 20681641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Host-guest inclusion system of mangiferin with β-cyclodextrin and its derivatives.
    Yang X; Zhao Y; Chen Y; Liao X; Gao C; Xiao D; Qin Q; Yi D; Yang B
    Mater Sci Eng C Mater Biol Appl; 2013 May; 33(4):2386-91. PubMed ID: 23498273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inclusion complexes of azadirachtin with native and methylated cyclodextrins: solubilization and binding ability.
    Liu Y; Chen GS; Chen Y; Lin J
    Bioorg Med Chem; 2005 Jun; 13(12):4037-42. PubMed ID: 15911316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation and characterization of simvastatin/hydroxypropyl-beta-cyclodextrin inclusion complex using supercritical antisolvent (SAS) process.
    Jun SW; Kim MS; Kim JS; Park HJ; Lee S; Woo JS; Hwang SJ
    Eur J Pharm Biopharm; 2007 Jun; 66(3):413-21. PubMed ID: 17240129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physicochemical, in silico and in vivo evaluation of a danazol-beta-cyclodextrin complex.
    Jadhav GS; Vavia PR
    Int J Pharm; 2008 Mar; 352(1-2):5-16. PubMed ID: 18023545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Artemether/hydroxypropyl-beta-cyclodextrin host-guest system: characterization, phase-solubility and inclusion mode.
    Yang B; Lin J; Chen Y; Liu Y
    Bioorg Med Chem; 2009 Sep; 17(17):6311-7. PubMed ID: 19665897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Supramolecular system of podophyllotoxin and hydroxypropyl-β-cyclodextrin: Characterization, inclusion mode, docking calculation, solubilization, stability and cytotoxic activity.
    Yang LJ; Wang SH; Zhou SY; Zhao F; Chang Q; Li MY; Chen W; Yang XD
    Mater Sci Eng C Mater Biol Appl; 2017 Jul; 76():1136-1145. PubMed ID: 28482478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sulfamethoxazole:hydroxypropyl-β-cyclodextrin complex: preparation and characterization.
    Garnero C; Aiassa V; Longhi M
    J Pharm Biomed Anal; 2012 Apr; 63():74-9. PubMed ID: 22361661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on trimethoprim:hydroxypropyl-β-cyclodextrin: aggregate and complex formation.
    Garnero C; Zoppi A; Genovese D; Longhi M
    Carbohydr Res; 2010 Nov; 345(17):2550-6. PubMed ID: 20933225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigation of inclusion complex of cilnidipine with hydroxypropyl-β-cyclodextrin.
    Hu L; Zhang H; Song W; Gu D; Hu Q
    Carbohydr Polym; 2012 Nov; 90(4):1719-24. PubMed ID: 22944438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular simulation of hydroxypropyl-beta-cyclodextrin with hydrophobic selective Cox-II chemopreventive agent using host-guest phenomena.
    Sinha VR; Nanda A; Chadha R; Goel H
    Acta Pol Pharm; 2011; 68(4):585-92. PubMed ID: 21796941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study of freeze-dried quercetin-cyclodextrin binary systems by DSC, FT-IR, X-ray diffraction and SEM analysis.
    Pralhad T; Rajendrakumar K
    J Pharm Biomed Anal; 2004 Feb; 34(2):333-9. PubMed ID: 15013147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Host-guest system of hesperetin and β-cyclodextrin or its derivatives: Preparation, characterization, inclusion mode, solubilization and stability.
    Yang LJ; Xia S; Ma SX; Zhou SY; Zhao XQ; Wang SH; Li MY; Yang XD
    Mater Sci Eng C Mater Biol Appl; 2016 Feb; 59():1016-1024. PubMed ID: 26652460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation.
    Badr-Eldin SM; Elkheshen SA; Ghorab MM
    Eur J Pharm Biopharm; 2008 Nov; 70(3):819-27. PubMed ID: 18655829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation and characterization of inclusion complexes of prazosin hydrochloride with beta-cyclodextrin and hydroxypropyl-beta-cyclodextrin.
    Liu L; Zhu S
    J Pharm Biomed Anal; 2006 Jan; 40(1):122-7. PubMed ID: 16095859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study of ascorbic acid interaction with hydroxypropyl-beta-cyclodextrin and triethanolamine, separately and in combination.
    Garnero C; Longhi M
    J Pharm Biomed Anal; 2007 Nov; 45(4):536-45. PubMed ID: 17851014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Solid-state characterization and dissolution profiles of the inclusion complexes of omeprazole with native and chemically modified beta-cyclodextrin.
    Figueiras A; Carvalho RA; Ribeiro L; Torres-Labandeira JJ; Veiga FJ
    Eur J Pharm Biopharm; 2007 Sep; 67(2):531-9. PubMed ID: 17451924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.